Profitability Metrics

Gross Margin
42.05%
Operating Margin
10.78%
Net Margin
3.99%

Efficiency Metrics

Revenue per Expense Ratio
1.12
R&D as % of Revenue
0.00%

Earnings Quality

EBITDA Margin
35.12%
Income Tax Rate
11.16%
EPS
0.8400000000

Balance Sheet Analysis

Current Ratio
0.86
Cash Ratio
0.05
Working Capital
$-59.29M
Debt to Equity
1.02
Debt to Assets
33.87%
Equity Ratio
33.10%

Cash Flow Analysis

Operating Cash Flow Ratio
54.81%
Free Cash Flow Ratio
6.93%
CapEx to Revenue
47.88%
Dividends Paid
$183.80M
Stock Buybacks
$3.96M
Total Shareholder Returns
$187.75M
Cash Position Change
-31.07%

Key Takeaways (2024 FY)

  • Revenue declined by 10.532894219308%, indicating potential market challenges
  • Increased dividend payments by 4.33%

Detailed Growth Metrics

Core Performance

Revenue
-10.53%
Net Income
-83.75%
EPS
-83.85%
Operating Income
-72.23%

Operational Efficiency

R&D Expenses
0.00%
SG&A Expenses
-100.00%
Operating Cash Flow
-13.83%
Free Cash Flow
-40.70%

Balance Sheet Health

Assets
0.48%
Debt
4.00%
Book Value per Share
-3.93%
Inventory
1.51%

Shareholder Returns

Dividends per Share
4.33%
Shares Outstanding
0.05%

Long Term Trends

3Y Revenue/Share
10.80%
5Y Revenue/Share
7.90%
3Y Dividend/Share
11.89%
5Y Dividend/Share
17.13%